CTCs in Lung Malignancies
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/08/035450
- Lead Sponsor
- Datar Cancer Genetics Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Provision of signed dated informed consent form.
Suspected to have malignancy or newly diagnosed for lung malignancy(therapy na�¯ve)
Exclusion Criteria
Failure to meet any or all of the above criteria.
Positive for HIV, HBV, HCV, or tuberculosis.
Received any type or anticancer treatment since diagnosis; includes systemic therapy, radiation or surgery.
Received blood transfusion within last 30 days.
Underwent PET-CT scan within last 5 days.
Unable to undergo tissue biopsy as part of Standard diagnostic Workup.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study the concordance of circulating tumor cells-based study with biopsy in patients with newly diagnosed lung epithelial malignancyTimepoint: Six Months
- Secondary Outcome Measures
Name Time Method To study the concordance of circulating tumor cells-based study with biopsy in patients with newly diagnosed lung epithelial malignancyTimepoint: Six Months